Lifecore Biomedical Inc
LFCR7.930USD
+0.230+2.99%
收盘 09/18, 16:00（美东）报价延迟15分钟
293.62M总市值
亏损市盈率 TTM
关于 Lifecore Biomedical Inc 公司
Lifecore Biomedical, Inc. 是一家完全一体化的合同开发和制造组织 (CDMO)。该公司为生物材料市场设计、开发、制造和销售差异化产品，并向合作伙伴授权技术应用。该公司在注射器和小瓶中无菌注射级药品的开发、灌装和完成方面提供高度差异化的能力。该公司参与制造散装药用级透明质酸钠 (HA)，以及用于治疗一系列医疗状况和程序的注射产品的配制和灌装注射器和小瓶。该公司利用其发酵工艺和无菌配方和灌装专业知识来开发用于多种应用的基于 HA 的产品，并利用非 HA 设备和药物机会。
公司简介
公司代码LFCR
公司名称Lifecore Biomedical Inc
上市日期Feb 15, 1996
CEOMr. Paul Josephs
员工数量406
证券类型Ordinary Share
年结日Feb 15
公司地址3515 Lyman Boulevard
城市CHASKA
上市交易所NASDAQ Global Select Consolidated
国家United States of America
邮编55318
电话19523684300
网址https://www.lifecore.com/
公司代码LFCR
上市日期Feb 15, 1996
CEOMr. Paul Josephs
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Thomas (Tom) Salus
Mr. Thomas (Tom) Salus
Chief Legal and Administrative Officer , Corporate Secretary
Chief Legal and Administrative Officer , Corporate Secretary
240.98K
+12.08%
Mr. Paul Josephs
Mr. Paul Josephs
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
133.33K
+249.16%
Mr. Joshua E. Schechter
Mr. Joshua E. Schechter
Independent Director
Independent Director
79.17K
+32.69%
Mr. Ryan David Lake
Mr. Ryan David Lake
Chief Financial Officer, Executive Vice President, Company Secretary
Chief Financial Officer, Executive Vice President, Company Secretary
74.19K
-23.61%
Mr. Jason M. Aryeh
Mr. Jason M. Aryeh
Independent Director
Independent Director
44.06K
+79.44%
Mr. Nelson Obus
Mr. Nelson Obus
Independent Director
Independent Director
19.51K
--
Ms. Jackie Klecker
Ms. Jackie Klecker
Executive Vice President - Quality and Development Services
Executive Vice President - Quality and Development Services
--
--
Mr. Christopher Kiper
Mr. Christopher Kiper
Independent Director
Independent Director
--
--
Mr. Humberto C. Antunes, M.D.
Mr. Humberto C. Antunes, M.D.
Independent Director
Independent Director
--
--
Ms. Stephanie Diaz
Ms. Stephanie Diaz
IR Contact Officer
IR Contact Officer
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Thomas (Tom) Salus
Mr. Thomas (Tom) Salus
Chief Legal and Administrative Officer , Corporate Secretary
Chief Legal and Administrative Officer , Corporate Secretary
240.98K
+12.08%
Mr. Paul Josephs
Mr. Paul Josephs
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
133.33K
+249.16%
Mr. Joshua E. Schechter
Mr. Joshua E. Schechter
Independent Director
Independent Director
79.17K
+32.69%
Mr. Ryan David Lake
Mr. Ryan David Lake
Chief Financial Officer, Executive Vice President, Company Secretary
Chief Financial Officer, Executive Vice President, Company Secretary
74.19K
-23.61%
Mr. Jason M. Aryeh
Mr. Jason M. Aryeh
Independent Director
Independent Director
44.06K
+79.44%
Mr. Nelson Obus
Mr. Nelson Obus
Independent Director
Independent Director
19.51K
--
收入明细
单位: USD更新时间: 3月4日 周二
单位: USD更新时间: 3月4日 周二
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Contract development and manufacturing organization ("CDMO")
17.81M
64.53%
Fermentation
8.52M
30.87%
Olive oil and wine vinegars
1.27M
4.60%
Technology
0.00
0.00%
地区USD
名称
营收
占比
United States
16.40M
59.42%
Switzerland
6.80M
24.64%
Ireland
1.10M
3.99%
Australia
1.10M
3.99%
Canada
700.00K
2.54%
其他
1.50M
5.43%
业务
地区
业务USD
名称
营收
占比
Contract development and manufacturing organization ("CDMO")
17.81M
64.53%
Fermentation
8.52M
30.87%
Olive oil and wine vinegars
1.27M
4.60%
Technology
0.00
0.00%
股东统计
更新时间: 8月19日 周二
更新时间: 8月19日 周二
持股股东
股东类型
持股股东
持股股东
占比
Wynnefield Capital, Inc.
12.70%
Legion Partners Asset Management, LLC
11.97%
Greenhaven Road Investment Management, L.P.
9.98%
325 Capital LLC
5.84%
Laughing Water Capital, LP
5.13%
其他
54.38%
持股股东
持股股东
占比
Wynnefield Capital, Inc.
12.70%
Legion Partners Asset Management, LLC
11.97%
Greenhaven Road Investment Management, L.P.
9.98%
325 Capital LLC
5.84%
Laughing Water Capital, LP
5.13%
其他
54.38%
股东类型
持股股东
占比
Hedge Fund
30.83%
Investment Advisor
24.98%
Investment Advisor/Hedge Fund
18.56%
Individual Investor
1.99%
Research Firm
1.84%
Bank and Trust
0.12%
Private Equity
0.08%
Venture Capital
0.05%
Insurance Company
0.02%
其他
21.53%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
212
27.35M
73.90%
-2.82M
2025Q1
229
29.94M
81.56%
-2.38M
2024Q4
243
30.30M
82.90%
-2.02M
2024Q3
234
26.35M
84.61%
-494.37K
2024Q2
224
23.91M
77.61%
-4.44M
2024Q1
225
24.56M
80.40%
-3.68M
2023Q4
221
23.64M
77.94%
-3.68M
2023Q3
229
20.71M
68.28%
-6.48M
2023Q2
237
20.72M
68.32%
-8.44M
2023Q1
244
23.24M
76.67%
-6.53M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Wynnefield Capital, Inc.
4.70M
12.7%
--
--
Mar 31, 2025
Legion Partners Asset Management, LLC
4.43M
11.97%
--
--
Mar 31, 2025
Greenhaven Road Investment Management, L.P.
3.62M
9.77%
--
--
Mar 31, 2025
325 Capital LLC
2.16M
5.84%
+1.37M
+172.80%
Mar 31, 2025
Laughing Water Capital, LP
1.90M
5.13%
+321.80K
+20.39%
Feb 18, 2025
David Capital Partners, LLC
1.80M
4.87%
+148.00K
+8.94%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
1.63M
4.41%
+134.35K
+8.97%
Mar 31, 2025
The Vanguard Group, Inc.
1.55M
4.18%
+15.96K
+1.04%
Mar 31, 2025
Geode Capital Management, L.L.C.
750.50K
2.03%
+64.75K
+9.44%
Mar 31, 2025
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
